[Drug of the month. Varenicline (Champix)]
- PMID: 17461303
[Drug of the month. Varenicline (Champix)]
Abstract
Smoking is responsible for 20,000 premature deaths per year in Belgium. Paradoxically, few drugs are efficient to induce tobacco cessation and to decrease relapse. Until a few weeks ago nicotin replacement therapy and bupropion only were validated in this indication. Varenicline (Champix), a partial agonist of nicotinic receptors, is a novel type of drugs currently also accepted for sale for smoking cessation. This article dwells on recent publications about efficacy of varenicline. Position, side-effects and advantages of the drug are discussed.
Similar articles
-
Varenicline for smoking cessation: definite promise, but no panacea.JAMA. 2006 Jul 5;296(1):94-5. doi: 10.1001/jama.296.1.94. JAMA. 2006. PMID: 16820552 No abstract available.
-
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.Arch Intern Med. 2006 Aug 14-28;166(15):1561-8. doi: 10.1001/archinte.166.15.1561. Arch Intern Med. 2006. PMID: 16908788 Clinical Trial.
-
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56. JAMA. 2006. PMID: 16820547 Clinical Trial.
-
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?Expert Opin Pharmacother. 2007 Dec;8(17):2903-15. doi: 10.1517/14656566.8.17.2903. Expert Opin Pharmacother. 2007. PMID: 18001252 Review.
-
Non-nicotinic therapies for smoking cessation.Annu Rev Pharmacol Toxicol. 2007;47:541-64. doi: 10.1146/annurev.pharmtox.47.120505.105354. Annu Rev Pharmacol Toxicol. 2007. PMID: 17209799 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical